Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
复制标题
半胱氨酸双加氧酶 1 介导人胃癌细胞中 Erastin 诱导的铁死亡
DOI:
10.1016/j.neo.2017.10.005
复制
发表时间:
2017-12
期刊:
影响因子:
--
通讯作者:
Shi M
中科院分区:
文献类型:
--
作者:
Hao S;Yu J;He W;Huang Q;Zhao Y;Liang B;Zhang S;Wen Z;Dong S;Rao J;Liao W;Shi M
BACKGROUND: Ferroptosis is a recently discovered form of iron-dependent nonapoptotic cell death. It is characterized by loss of the activity of the lipid repair enzyme, glutathione peroxidase 4 (GPX4), and accumulation of lethal reactive lipid oxygen species. However, we still know relatively little about ferroptosis and its molecular mechanism in gastric cancer (GC) cells. Here, we demonstrate that erastin, a classic inducer of ferroptosis, induces this form of cell death in GC cells and that cysteine dioxygenase 1 (CDO1) plays an important role in this process. METHODS: We performed quantitative real-time polymerase chain reaction, Western blotting, cell viability assay, reactive oxygen species (ROS) assay, glutathione assay, lipid peroxidation assay, RNAi and gene transfection, immunofluorescent staining, dual-luciferase reporter assay, transmission electron microscopy, and chromatin immunoprecipitation assay to study the regulation of ferroptosis in GC cells. Mouse xenograft assay was used to figure out the mechanism in vivo. RESULTS: Silencing CDO1 inhibited erastin-induced ferroptosis in GC cells both in vitro and in vivo. Suppression of CDO1 restored cellular GSH levels, prevented ROS generation, and reduced malondialdehyde, one of the end products of lipid peroxidation. In addition, silencing COO1 maintained mitochondrial morphologic stability in erastin-treated cells. Mechanistically, c-Myb transcriptionally regulated CDO1, and inhibition of CDO1 expression upregulated GPX4 expression. CONCLUSIONS: Our findings give a better understanding of ferroptosis and its molecular mechanism in GC cells, gaining insight into ferroptosis-mediated cancer treatment.
登录
查看更多内容
影响因子:
2.1
作者:
Conrad M;Friedmann Angeli JP
通讯作者:
Friedmann Angeli JP
影响因子:
64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者:
Stockwell BR
影响因子:
11.4
作者:
Booken, N.;Gratchev, A.;Goerdt, S.
通讯作者:
Goerdt, S.
影响因子:
2.3
作者:
Gout, PW;Simms, CR;Robertson, MC
通讯作者:
Robertson, MC
影响因子:
3.5
作者:
Jurkowska, Halina;Stipanuk, Martha H.;Hirschberger, Lawrence L.;Roman, Heather B.
通讯作者:
Roman, Heather B.